Moderna (MRNA) Billionaire Afeyan Adds to Fortune as Sigilon Stock (SGTX) Soars - Bloomberg
Moderna/biotech: cure all
Welcome to the Office of Economy and Labour (AWA) - Moderna drives vaccine production from Basel
US biotech: Moderna's art
Moderna seeks U.S. authorization for COVID-19 vaccine booster | Reuters
Moderna says COVID-19 vaccine supply outside United States to slow down | Reuters
Moderna Sues Pfizer and BioNTech Over Covid Vaccine Technology - The New York Times
Readout Newsletter: Biotech news, including Moderna's Covid vaccine
Moderna, AbCellera join forces to tackle major mRNA opportunity | Fierce Biotech
US biotech Moderna strikes deal to develop mRNA drugs in China
AstraZeneca sold its stake in Moderna for more than $1 billion, as it looks to develop its own pipeline of drugs - MarketWatch
Moderna buys small Japanese biotech for its manufacturing technology - The Boston Globe
Moderna Navigates Growth, Flexible Work + Innovation - Steelcase
Fact check: Dr. Fauci was not the first CEO and other false claims about biotech company Moderna | Reuters
Moderna Files for Largest-Ever Biotech IPO, Seeking to Raise $500M
After a big year, Moderna becomes the third largest biotech employer based in Mass. - The Boston Globe
Moderna's manufacturing operations reveal state of the company
With new vaccine technology, small biotech firm Moderna battles mighty pandemic | The Times of Israel
Be Careful Handling White-Hot Moderna Stock - WSJ
Moderna CFO's departure reignites debate over company's culture
Moderna's Vaccine Candidate Heads To Testing In Up To 30,000 People : Coronavirus Updates : NPR
4 big questions ahead of Moderna's public debut — biotech's biggest ever
Moderna's commercial lead ousted as mRNA biotech taps leading execs to front all sales, marketing work | Fierce Pharma
Biotech Companies Moderna, Lonza Group Partner to Manufacture Potential Coronavirus Vaccine
